Patients treated with ALYGLO™ receive one infusion every three to four weeks administered by a nurse either at home or at an infusion center. GC Biopharma selected AOM Infusion as a partner ...

DALLAS, January 13, 2025--(BUSINESS WIRE)--AIC, a division of AIS Healthcare, now offers ALYGLO™, manufactured ... The nationally accredited home infusion teams at AIC collaborate closely ...

ALYGLO is a liquid solution containing 10% immunoglobulin G (100 mg/mL) for intravenous infusion, manufactured from pooled human plasma from US donors. The manufacturing process includes three ...

July 30, 2024 (GLOBE NEWSWIRE) -- KabaFusion, a nationally recognized leader in home infusion, has been selected by GC Biopharma USA, Inc. as a limited distribution partner to provide ALYGLO ...

The FDA is pushing back the approval of GC Pharma’s blood derivative ALYGLO (IVIG-SN 10%) in a complete response letter that cited a delay in the on-site inspection of the company’s ...

Following the successful U.S. launch of ALYGLO (immune globulin intravenous, human-stwk) 10% Liquid, GC Biopharma acquired ABO Holdings in January to support the product's expected mid-to long ...